These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 28100786)
21. Valproate activates the Snf1 kinase in Saccharomyces cerevisiae by decreasing the cytosolic pH. Salsaa M; Aziz K; Lazcano P; Schmidtke MW; Tarsio M; Hüttemann M; Reynolds CA; Kane PM; Greenberg ML J Biol Chem; 2021 Oct; 297(4):101110. PubMed ID: 34428448 [TBL] [Abstract][Full Text] [Related]
22. Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Harwood AJ Mol Psychiatry; 2005 Jan; 10(1):117-26. PubMed ID: 15558078 [TBL] [Abstract][Full Text] [Related]
23. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers. Teo R; King J; Dalton E; Ryves J; Williams RS; Harwood AJ Biochem Soc Trans; 2009 Oct; 37(Pt 5):1110-4. PubMed ID: 19754462 [TBL] [Abstract][Full Text] [Related]
24. Valproate regulates inositol synthesis by reducing expression of myo-inositol-3-phosphate synthase. Case KC; Beltman RJ; Pflum MKH; Greenberg ML Sci Rep; 2023 Sep; 13(1):14844. PubMed ID: 37684289 [TBL] [Abstract][Full Text] [Related]
25. Involvement of the mitochondrial retrograde pathway in dihydrosphingosine-induced cytotoxicity in budding yeast. Takayama C; Koga A; Sakamoto R; Arita N; Tani M Biochem Biophys Res Commun; 2022 May; 605():63-69. PubMed ID: 35316765 [TBL] [Abstract][Full Text] [Related]
26. Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs. Agam G; Shamir A; Shaltiel G; Greenberg ML Bipolar Disord; 2002; 4 Suppl 1():15-20. PubMed ID: 12479670 [TBL] [Abstract][Full Text] [Related]
27. Following the flux of long-chain bases through the sphingolipid pathway in vivo using mass spectrometry. Martínez-Montañés F; Schneiter R J Lipid Res; 2016 May; 57(5):906-15. PubMed ID: 26977056 [TBL] [Abstract][Full Text] [Related]
28. The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates. Dixon JF; Hokin LE Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4757-60. PubMed ID: 9114064 [TBL] [Abstract][Full Text] [Related]
29. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain? Lenox RH; McNamara RK; Watterson JM; Watson DG J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502 [TBL] [Abstract][Full Text] [Related]
30. Analysis of phosphorylated sphingolipid long-chain bases reveals potential roles in heat stress and growth control in Saccharomyces. Skrzypek MS; Nagiec MM; Lester RL; Dickson RC J Bacteriol; 1999 Feb; 181(4):1134-40. PubMed ID: 9973338 [TBL] [Abstract][Full Text] [Related]
31. A novel pathway of ceramide metabolism in Saccharomyces cerevisiae. Voynova NS; Vionnet C; Ejsing CS; Conzelmann A Biochem J; 2012 Oct; 447(1):103-14. PubMed ID: 22738231 [TBL] [Abstract][Full Text] [Related]
32. Effect of memantine on C-reactive protein and lipid profiles in bipolar disorder. Chang HH; Chen PS; Wang TY; Lee SY; Chen SL; Huang SY; Hong JS; Yang YK; Lu RB J Affect Disord; 2017 Oct; 221():151-157. PubMed ID: 28646711 [TBL] [Abstract][Full Text] [Related]
33. Lithium and valproate decrease the membrane phosphatidylinositol/phosphatidylcholine ratio. Ding D; Greenberg ML Mol Microbiol; 2003 Jan; 47(2):373-81. PubMed ID: 12519189 [TBL] [Abstract][Full Text] [Related]
34. Combined treatment of myo-inositol and d-chiro-inositol (80:1) as a therapeutic approach to restore inositol eumetabolism in patients with bipolar disorder taking lithium and valproic acid. Janiri L; D'Ambrosio F; Di Lorenzo C Eur Rev Med Pharmacol Sci; 2021 Sep; 25(17):5483-5489. PubMed ID: 34533796 [TBL] [Abstract][Full Text] [Related]
35. Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women? Akdeniz F; Taneli F; Noyan A; Yüncü Z; Vahip S Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):115-21. PubMed ID: 12551733 [TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of Saccharomyces cerevisiae dihydrosphingosine-1-phosphate phosphatase. Mao C; Wadleigh M; Jenkins GM; Hannun YA; Obeid LM J Biol Chem; 1997 Nov; 272(45):28690-4. PubMed ID: 9353337 [TBL] [Abstract][Full Text] [Related]
37. Effects of lithium and valproate on behavioral parameters and neurotrophic factor levels in an animal model of mania induced by paradoxical sleep deprivation. Dal-Pont GC; Jório MTS; Resende WR; Gava FF; Aguiar-Geraldo JM; Possamai-Della T; Peper-Nascimento J; Quevedo J; Valvassori SS J Psychiatr Res; 2019 Dec; 119():76-83. PubMed ID: 31574363 [TBL] [Abstract][Full Text] [Related]
38. Induction of apoptosis by sphingoid long-chain bases in Aspergillus nidulans. Cheng J; Park TS; Chio LC; Fischl AS; Ye XS Mol Cell Biol; 2003 Jan; 23(1):163-77. PubMed ID: 12482970 [TBL] [Abstract][Full Text] [Related]
39. How can the mood stabilizer VPA limit both mania and depression? Cheng L; Lumb M; Polgár L; Mudge AW Mol Cell Neurosci; 2005 Jun; 29(2):155-61. PubMed ID: 15911340 [TBL] [Abstract][Full Text] [Related]
40. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder? Haymond J; Ensom MH Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]